TREATMENT OF RESTING ZONE CHONDROCYTES WITH 24,25-DIHYDROXYVITAMIN D-3[24,25-(OH)(2)D-3] INDUCES DIFFERENTIATION INTO A 1,25-(OH)(2)D-3-RESPONSIVE PHENOTYPE CHARACTERISTIC OF GROWTH ZONE CHONDROCYTES

被引:46
|
作者
SCHWARTZ, Z
DEAN, DD
WALTON, JK
BROOKS, BP
BOYAN, BD
机构
[1] UNIV TEXAS, HLTH SCI CTR, DEPT ORTHOPED, SAN ANTONIO, TX 78284 USA
[2] HEBREW UNIV JERUSALEM, HADASSAH FAC DENT MED, DEPT PERIODONT, IL-92010 JERUSALEM, ISRAEL
[3] UNIV TEXAS, HLTH SCI CTR, DEPT PERIODONT, SAN ANTONIO, TX 78284 USA
[4] UNIV TEXAS, HLTH SCI CTR, DEPT BIOCHEM, SAN ANTONIO, TX 78284 USA
关键词
D O I
10.1210/en.136.2.402
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vitamin D-3 metabolites affect the proliferation and differentiation of cartilage cells. Previous reports have shown that rat costochondral cartilage chondrocytes isolated from the growth zone (GC) respond to 1,25-dihydroxyvitamin D-3 [1,25-(OH)(2)D-3], whereas those from the resting zone (RC) respond to 24,25-(OH)(2)D-3. The aim of the present study was to determine whether 24,25-(OH)(2)D-3 induces differentiation of RC cells into a 1,25-(OH)(2)D-3-responsive GC phenotype. To do this, confluent, fourth passage RC chondrocytes were pretreated for 24, 36, 48, 72, and 120 h with 10(-7) M 24,25-(OH)(2)D-3. The medium was then replaced with new medium containing 10(-10) to 10(-8) M 1,25-(OH)(2)D-3, and the cells were incubated for an additional 24 h. At harvest, DNA synthesis was measured as a function of [H-3]thymidine incorporation; cell maturation was assessed by measuring alkaline phosphatase (ALPase) specific activity. Incorporation of [H-3]uridine was used as a general indicator of RNA synthesis. Matrix protein synthesis was assessed by measuring incorporation of [H-3]proline into collagenase-digestible protein (CDP) and collagenase-nondigestible protein (NCP) as well as (SO4)-S-35 incorporation into proteoglycans. When RC cells were pretreated for 24 h with 24,25-(OH)(2)D-3, they responded like RC cells that had received no pretreatment; further treatment of these cells with 1,25-(OH)(2)D-3 had no effect on ALPase, proteoglycan, or NCP production, but CDP production was inhibited. However, when RC cells were pretreated for 36-120 h with 24,25-(OH)(2)D-3, treatment with 1,25-(OH)(2)D-3 caused a dose-dependent increase in ALPase, CDP, and proteoglycan synthesis, with no effect on NCP production. RC cells pretreated with 1,25-(OH)(2)D-3 responded like RC cells that had not received any pretreatment. To determine whether these responses were specific to chondrocytes in the endochondral pathway, cells were isolated from the xiphoid process, a hyaline cartilage. In these cells, 1,25-(OH)(2)D-3 inhibited ALPase, whereas 36 h of pretreatment with 24,25-(OH)(2)D-3 caused these cells to lose their response to 1,25-(OH)(2)D-3. These results indicate that 24,25-(OH)(2)D-3 can directly regulate the differentiation and maturation of RC chondrocytes into GC chondrocytes, as evidenced by increased responsiveness to 1,25-(OH)(2)D-3 24,25-(OH)(2)D-3 also promotes differentiation of cells derived from xiphoid cartilage, resulting in the loss of 1,25-(OH)(2)D-3 responsiveness. These observations support the hypothesis that 24,25-(OH)(2)D-3 plays a significant role in cartilage development.
引用
收藏
页码:402 / 411
页数:10
相关论文
共 50 条
  • [31] Differential regulation of protein kinase C by 24,25-(OH)(2)D-3 during matrix vesicle formation and maturation
    Holmes, S
    Sylvia, VL
    Dean, DD
    Schwartz, Z
    Boyan, BD
    JOURNAL OF DENTAL RESEARCH, 1997, 76 : 2309 - 2309
  • [32] Metabolism of 25-(OH)D-3 in vivo results in preferential accumulation of 24R,25-(OH)(2)D-3 in growth plate cartilage.
    Seo, EG
    Schwartz, Z
    Dean, DD
    Norman, AW
    Boyan, BD
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : T492 - T492
  • [33] Nongenomic regulation of protein kinase C isoforms by the vitamin D metabolites 1 alpha,25-(OH)(2)D-3 and 24R,25-(OH)(2)D-3
    Sylvia, VL
    Schwartz, Z
    Ellis, EB
    Helm, SH
    Gomez, R
    Dean, DD
    Boyan, BD
    JOURNAL OF CELLULAR PHYSIOLOGY, 1996, 167 (03) : 380 - 393
  • [34] Metalloproteinase activity in growth plate chondrocyte cultures is regulated by 1,25-( OH)2D3 and 24,25-( OH)2D3 and mediated through protein kinase C
    Maeda, S
    Dean, DD
    Sylvia, VL
    Boyan, BD
    Schwartz, Z
    MATRIX BIOLOGY, 2001, 20 (02) : 87 - 97
  • [35] 24,25-(OH)(2)D-3 regulates protein kinase C through two distinct phospholipid-dependent mechanisms
    Helm, S
    Sylvia, VL
    Harmon, T
    Dean, DD
    Boyan, BD
    Schwartz, Z
    JOURNAL OF CELLULAR PHYSIOLOGY, 1996, 169 (03) : 509 - 521
  • [36] HUMAN ARTICULAR CHONDROCYTES ACQUIRE 1,25-(OH)2VITAMIN-D3 (1,25-(OH)2D3) RECEPTORS IN CULTURE
    GOLDRING, MB
    BHALLA, AK
    WOJNO, W
    KRANE, SM
    JOURNAL OF BONE AND MINERAL RESEARCH, 1986, 1 (01) : 93 - 93
  • [37] 24R,25-(OH)(2) vitamin D-3 inhibits 1 alpha,25-(OH)(2) vitamin D-3 and testosterone potentiation of calcium channels in osteosarcoma cells
    Takeuchi, K
    Guggino, SE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (52) : 33335 - 33343
  • [38] Anti-tumor effects of 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) in seborrheic keratosis
    Asagami, C
    Muto, M
    Hirota, T
    Shimizu, T
    Hamamoto, Y
    JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 1, APRIL 1996: VITAMIN D: ACTIONS AND APPLICATIONS IN DERMATOLOGY, 1996, 1 : 94 - 96
  • [39] 24,25(OH)2D3 ENHANCES THE CALCEMIC EFFECT OF 1,25(OH)2D3 - EVIDENCE FOR HYPOCALCIURIC ACTION OF 24,25(OH)2D3
    POPOVTZER, MM
    HAYEK, T
    WALD, H
    KIDNEY INTERNATIONAL, 1983, 23 (01) : 108 - 108
  • [40] ACTION OF 1,25(OH)2D3 AND 24,25(OH)2D3 ON BONE - EVIDENCE FOR BIOLOGICAL-ACTIVITY OF 24,25(OH)2D3
    MALLUCHE, HH
    SHERMAN, D
    MEYER, W
    HENRY, H
    NORMAN, AW
    MASSRY, SG
    KIDNEY INTERNATIONAL, 1979, 16 (06) : 828 - 828